Business Description
Echo IQ Limited is an Australian medical technology company that develops AI-powered tools to help doctors more accurately diagnose serious heart conditions, including aortic stenosis, diastolic dysfunction, and heart failure. Its flagship product, EchoSolv, analyzes patient data to produce risk assessments that support faster and more informed clinical decisions. The company operates out of Claremont, Australia, and rebranded under its current name in December 2021.